Symbol
| HOXA5
| contributors: mct - updated : 19-05-2012
|
HGNC name
| homeobox A5
|
HGNC id
| 5106
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in nearly 70 p100 of all breast carcinomas | tumoral
|  
|  
| --low
|  
|
by hypermethylation in acute myeloid leukemia, but low level of HOXA5 hypermethylation is associated with short-term outcome | constitutional
|  
| deletion
|  
|  
|
leads to anterior forelimb defects resulting from derepression of SHH expression | |
Variant & Polymorphism
|
| |
Candidate gene
| candidate gene of androgen-mediated promoter methylation |
Marker
Therapy target
| | |
| deregulation of the estrous cycle and the presence of ovarian epithelial cysts in Hoxa5(-/-) older murine females correlate with a reduced expression of specific epidermal growth factor receptor signaling components, namely Egfr, Areg, and Btc |